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Discovering that transcranial infrared laser
stimulation produces beneficial effects
on frontal cortex functions such as sus-
tained attention, working memory, and
affective state has been groundbreaking.
Transcranial laser stimulation with low-
power density (mW/cm2) and high-energy
density (J/cm2) monochromatic light
in the near-infrared wavelengths modu-
lates brain functions and may produce
neurotherapeutic effects in a nondestruc-
tive and non-thermal manner (Lampl,
2007; Hashmi et al., 2010). Barrett and
Gonzalez-Lima (2013) provided the first
controlled study showing that transcra-
nial laser stimulation improves human
cognitive and emotional brain functions.
But for the field of low-level light/laser
therapy (LLLT), development of a model
of how luminous energy from red-to-
near-infrared wavelengths modulates
bioenergetics began with in vitro and
in vivo discoveries in the last 40 years.
Previous LLLT reviews have provided
extensive background about historical
developments, principles and applica-
tions (Rojas and Gonzalez-Lima, 2011,
2013; Chung et al., 2012). The purpose
of this paper is to provide an update on
LLLT’s neurochemical mechanisms sup-
porting transcranial laser stimulation for
cognitive-enhancing applications. We will
explain first LLLT’s action on brain bioen-
ergetics, briefly describe its bioavailability
and dose-response, and finish with its
beneficial effects on cognitive functions.
Although our focus is on prefrontal-
related cognitive functions, in principle
LLLT should be able to modulate other
brain functions. For example, stimulat-
ing different brain regions should affect
different functions related to sensory and
motor systems.
BRAIN BIOENERGETICS
The way that near-infrared lasers and
light-emitting diodes (LEDs) interact with
brain function is based on bioenergetics,
a mechanism that is fundamentally differ-
ent than that of other brain stimulation
methods such as electric and magnetic
stimulation. LLLT has been found to
modulate the function of neurons in
cell cultures, brain function in animals,
and cognitive and emotional functions
in healthy persons and clinical con-
ditions. Photoneuromodulation involves
the absorption of photons by specific
molecules in neurons that activate bioen-
ergetic signaling pathways after expo-
sure to red-to-near-infrared light. The
600–1150 nm wavelengths allow better tis-
sue penetration by photons because light
is scattered at lower wavelengths and
absorbed by water at higher wavelengths
(Hamblin and Demidova, 2006). Over 25
years ago, it was found that molecules
that absorb LLLT wavelengths are part
of the mitochondrial respiratory enzyme
cytochrome oxidase in different oxida-
tion states (Karu et al., 2005). Thus,
for red-to-near-infrared light, the pri-
mary molecular photoacceptor of photon
energy is cytochrome oxidase (also called
cytochrome c oxidase or cytochrome a-a3)
(Pastore et al., 2000).
Therefore, photon energy absorption
by cytochrome oxidase is well-established
as the primary neurochemical mecha-
nism of action of LLLT in neurons
(Wong-Riley et al., 2005). The more the
enzymatic activity of cytochrome oxidase
increases, the more metabolic energy that
is produced via mitochondrial oxidative
phosphorylation. LLLT supplies the brain
with metabolic energy in a way analo-
gous to the conversion of nutrients into
metabolic energy, but with light instead
of nutrients providing the source for ATP-
based metabolic energy (Mochizuki-Oda
et al., 2002). If an effective near-infrared
light energy dose is supplied, it stim-
ulates brain ATP production (Lapchak
and De Taboada, 2010) and blood flow
(Uozumi et al., 2010), thereby fueling
ATP-dependent membrane ion pumps,
leading to greater membrane stability and
resistance to depolarization, which has
been shown to transiently reduce neu-
ronal excitability (Konstantinovic et al.,
2013). On the other hand, electromagnetic
stimulation directly changes the electrical
excitability of neurons.
A long-lasting effect is achieved by
LLLT’s up-regulating the amount of
cytochrome oxidase, which enhances
neuronal capacity for metabolic energy
production that may be used to sup-
port cognitive brain functions. In mice
and rats, memory has been improved by
LLLT (Michalikova et al., 2008; Rojas
et al., 2012a) and by methylene blue,
a drug that at low doses donates elec-
trons to cytochrome oxidase (Rojas et al.,
2012b). Near-infrared light stimulates
mitochondrial respiration by donating
photons to cytochrome oxidase, because
cytochrome oxidase is the main acceptor
of photons from red-to-near-infrared light
in neurons. By persistently stimulating
cytochrome oxidase activity, transcranial
LLLT induces post-stimulation up-
regulation of the amount of cytochrome
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oxidase in brain mitochondria (Rojas
et al., 2012a). Therefore, LLLT may lead
to the conversion of luminous energy
into metabolic energy (during light
exposure) and to the up-regulation of
the mitochondrial enzymatic machin-
ery to produce more energy (after light
exposure).
BIOAVAILABILITY AND HORMETIC
DOSE-RESPONSE
The most abundant metalloprotein in
nerve tissue is cytochrome oxidase, and
its absorption wavelengths are well cor-
related with its enzymatic activity and
ATP production (Wong-Riley et al., 2005).
High LLLT bioavailability to the brain
in vivo has been shown by inducing
brain cytochrome oxidase activity tran-
scranially, leading to enhanced extinction
memory retention in normal rats (Rojas
et al., 2012a) and improved visual dis-
crimination in rats with impaired reti-
nal mitochondrial function (Rojas et al.,
2008). Our LLLT studies utilized varied
wavelengths (633–1064 nm), daily doses
(1–60 J/cm2), fractionation sessions (1–6),
and power densities (2–250mW/cm2) that
identified effective LLLT parameters for
rats and humans.
For example, we tested in rats the
effects of different LLLT doses in vivo
on brain cytochrome oxidase activity,
at either 10.9, 21.6, 32.9 J/cm2, or no
LLLT. Treatments were delivered for 20,
40, and 60min via four 660-nm LED
arrays with a power density of 9mW/cm2.
One day after the LLLT session, brains
were extracted, frozen, sectioned, and
processed for cytochrome oxidase histo-
chemistry. A 10.9 J/cm2 dose increased
cytochrome oxidase activity by 13.6%.
A 21.6 J/cm2 dose produced a 10.3%
increase. A non-significant cytochrome
oxidase increase of 3% was found after
the highest 32.9 J/cm2dose. Responses of
brain cytochrome oxidase to LLLT in vivo
were characterized by hormesis, with a low
dose being stimulatory, while higher doses
were less effective.
The first demonstration that LLLT
increased oxygen consumption in the rat
prefrontal cortex in vivo was provided by
Rojas et al. (2012a). Oxygen concentration
in the cortex of rats was measured using
fluorescence-quenching during LLLT at
9mW/cm2 and 660 nm. LLLT induced a
dose-dependent increase in oxygen con-
sumption of 5% after 1 J/cm2 and 16%
after 5 J/cm2. Since oxygen is used to form
water within mitochondria in a reaction
catalyzed by cytochrome oxidase, more
cytochrome oxidase activity should lead to
more oxygen consumption.
LLLT may offer some advantages over
other types of stimulation, because LLLT
non-invasively targets cytochrome oxi-
dase, a key enzyme for energy produc-
tion, with induced expression linked to
energy demand. Hence LLLT is mecha-
nistically specific and non-invasive, while
transcranial magnetic stimulation may be
non-specific, prolonged forehead electrical
stimulation may produce muscle spasms,
and deep brain or vagus nerve stimulations
are invasive.
COGNITIVE AND EMOTIONAL
FUNCTIONS
LLLT via commercial low-power sources
(such as FDA-cleared laser diodes and
LEDs) is a highly promising, afford-
able, non-pharmacological alternative for
improving cognitive function. LLLT deliv-
ers safe doses of light energy that are
sufficiently high to modulate neuronal
functions, but low enough to not result
in any damage (Wong-Riley et al., 2005).
In 2002, the FDA approved LLLT for
pain relief in cases of head and neck
pain, arthritis and carpal tunnel syndrome
(Fulop et al., 2010). LLLT has been used
non-invasively in humans after ischemic
stroke to improve neurological outcome
(Lampl et al., 2007). It also led to improved
recovery and reduced fatigue after exer-
cise (Leal Junior et al., 2010). One LLLT
stimulation session to the forehead, as
reported by Schiffer et al. (2009), pro-
duced a significant antidepressant effect in
depressed patients. No adverse side effects
were found either immediately or at 2
or 4 weeks after LLLT. Thus, these ben-
eficial LLLT treatments have been found
to be safe in humans. Even though LLLT
has been regarded as safe and received
FDA approval for pain treatment, the use
of transcranial lasers for cognitive aug-
mentation should be restricted to research
until further controlled studies support
this application for clinical use.
We used transcranial laser stimulation
to the forehead in a placebo-controlled,
randomized study, to influence cognitive
tasks related to the prefrontal cor-
tex, including a psychomotor vigilance
task (PVT) and a delayed match-to-
sample (DMS) memory task (Barrett
and Gonzalez-Lima, 2013). The PVT
assesses sustained attention, with partic-
ipants remaining vigilant during delay
intervals, and pushing a button when a
visual stimulus appears on a monitor.
Our laser stimulation targeted prefrontal
areas which are implicated in the sus-
tained attentional processes of the PVT
(Drummond et al., 2005). Similarly, the
DMS task engages the prefrontal cortex as
part of a network of frontal and parietal
brain regions (Nieder and Miller, 2004).
Healthy volunteers received continuous
wave near-infrared light intersecting
cytochrome oxidase’s absorption spec-
trum, delivered to the forehead using
a 1064 nm low-power laser diode (also
known as “cold laser”), which maximizes
tissue penetration due to its long wave-
length, and has been used in humans
for other indications. The power den-
sity (or irradiance), 250mW/cm2, as
well as the cumulative energy density (or
fluence), 60 J/cm2, were the same that
showed beneficial psychological effects in
Schiffer et al. (2009). This laser expo-
sure produces negligible heat and no
physical damage at the low power level
used. This laser apparatus is used safely
in a clinical setting by the supplier of
the laser (Cell Gen Therapeutics, HD
Laser Center, Dallas, TX). Reaction time
in the PVT was improved by the laser
treatment, as shown by a significant pre-
post reaction time change relative to
the placebo group. The DMS memory
task also revealed significant enhance-
ments in measures of memory retrieval
latency and number of correct trials, when
comparing the LLLT-treated with the
placebo group (Figure 1). Self-reported
positive and negative affective (emo-
tional) states were also measured using
the PANAS-X questionnaire before and
2 weeks after laser treatment. As com-
pared to the placebo, treated subjects
reported significantly improved affective
states. We suggest that this kind of tran-
scranial laser stimulation may serve as a
non-invasive and efficacious method to
augment cognitive brain functions related
to attention, memory, and emotional
functions.
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FIGURE 1 | Cognitive performance in the delayed match-to-sample
(DMS) memory task was improved after transcranial infrared
stimulation to the right forehead. The DMS task involves presentation of a
visual stimulus (grid pattern) on a screen. Then the stimulus disappears, and
the participant must remember the stimulus through a delay. Then two
choices appear, and the participant must decide which of these two is
identical to the previous stimulus (the “match”). Treated subjects showed
faster memory retrieval (left panel) and increased number of correct trials
(right panel) out of 30 trials when attempting to choose the correct grid
pattern. The function of frontal cortex regions, implicated in the attentional
mode network utilized during this visuospatial memory task, was augmented
by the laser treatment. Compared to baseline, this treatment also increased
by 5% the oxyhemoglobin concentration of the prefrontal cortex as
measured by near-infrared spectroscopy, both during the laser stimulation
and during post-treatment DMS performance (in preparation). The data for
the treated group consisted of n = 10 males and n = 10 females; the control
group also consisted of n = 10 males and n = 10 females. ∗Significant
treatment by pre-post score interaction, p < 0.05.
LLLT’s bioenergetics mechanisms lead-
ing to cognitive augmentation may also
be at play in its neuroprotective effects
(Gonzalez-Lima et al., 2013). LLLT’s
stimulation of mitochondrial respira-
tion should improve cellular function
due to increased metabolic energy, as
well as cellular survival after injury, due
to the antioxidant effects of increases
in cytochrome oxidase and superoxide
dismutase (Rojas et al., 2008).
Laser transmittance of the 1064-nm
wavelength at the forehead LLLT site was
estimated in a post-mortem human spec-
imen, which showed that approximately
2% of the light passed through the frontal
bone. This yielded an absorption coeffi-
cient of a = 0.24, similar to the reported
a = 0.22 transmittance through cranial
bone for this wavelength (Bashkatov and
Genina, 2006). Thus, we estimated that
about 1.2 J/cm2 of the 60 J/cm2 LLLT dose
applied reached the surface of the pre-
frontal cortex. This value is similar to
1 J/cm2, the peak effective LLLT dose in
neuron cultures for increasing cytochrome
oxidase activity (Rojas and Gonzalez-
Lima, 2011).
CONCLUSIONS
Transcranial absorption of photon energy
by cytochrome oxidase, the terminal
enzyme in mitochondrial respiration, is
proposed as the bioenergetic mechanism
of action of LLLT in the brain. Transcranial
LLLT up-regulates cortical cytochrome
oxidase and enhances oxidative phos-
phorylation. LLLT improves prefrontal
cortex-related cognitive functions, such
as sustained attention, extinction mem-
ory, working memory, and affective state.
Transcranial infrared stimulation may
be used efficaciously to support neu-
ronal mitochondrial respiration as a new
non-invasive, cognition-improving inter-
vention in animals and humans. This
fascinating new approach should also be
able to influence other brain functions
depending on the neuroanatomical site
stimulated and the stimulation parameters
used.
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